P
Paul H. Hayashi
Researcher at University of North Carolina at Chapel Hill
Publications - 44
Citations - 2381
Paul H. Hayashi is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Liver transplantation & Chronic liver disease. The author has an hindex of 22, co-authored 44 publications receiving 2012 citations. Previous affiliations of Paul H. Hayashi include Icahn School of Medicine at Mount Sinai & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Features and outcomes of 899 patients with drug-induced liver injury: The DILIN prospective study
Naga Chalasani,Herbert L. Bonkovsky,Robert J. Fontana,William M. Lee,Andrew Stolz,Jayant A. Talwalkar,K. Rajendar Reddy,Paul B. Watkins,Victor J. Navarro,Huiman X. Barnhart,Jiezhun Gu,Jose Serrano,Jawad Ahmad,Nancy Bach,Meena B. Bansal,Huiman X. Barnhart,Kimberly L. Beavers,Herbert L. Bonkovsky,Francisco O. Calvo,Charissa Y. Chang,Hari S. Conjeevaram,Gregory E. Conner,Jama M. Darling,Ynto S. de Boer,Douglas T. Dieterich,Frank DiPaola,Francisco A. Durazo,James E. Everhart,Robert J. Fontana,Marwan Ghabril,David Goldstein,Vani Gopalreddy,Priya Grewal,Paul H. Hayashi,Jay H. Hoofnagle,Neil Kaplowitz,Suthat Liangpunsakul,Steven N. Lichtman,Lawrence Liu,Victor Navarro,Joseph A. Odin,Simona Rossi,Mark W. Russo,Thomas D. Schiano,Averell H. Sherker,Raj Vuppalanchi,Paul B. Watkins,Steven Zacks,Amanda Balasco,Kristin Chesney,Audrey Corne,Sherrie Cummings,Gale Groseclose,Alex Hammett,Judy Hooker,Varun Kesar,Sophana Mao,Kenari Marks,Regina McFadden,Yolanda Melgoza,Sherif Mikhail,Susan Milstein,Wendy Morlan,Val Peacock,Nidia Rosado,Tracy Russell,Maricruz Vega,Manisha Verma,Patricia F. Walker,Rachana Yalamanchili,Michelle McClanahan-Crowder,Katherine Galan,Tuan Chau,Kowsalya Ragavan,Hoss Rostami,Carmel Puglisi-Scharenbroich,Rebecca Torrance,Rebekah Van Raaphorst +77 more
TL;DR: In this article, the authors present characteristics and subgroup analyses from the first 1257 patients enrolled in the study, and conclude that there are no differences in outcomes of patients with short vs long latency of DILI.
Journal ArticleDOI
Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
David E. Kleiner,Naga Chalasani,William M. Lee,Robert J. Fontana,Herbert L. Bonkovsky,Paul B. Watkins,Paul H. Hayashi,Timothy J. Davern,Victor Navarro,Rajender Reddy,Jayant A. Talwalkar,Andrew Stolz,Jiezhun Gu,Huiman X. Barnhart,Jay H. Hoofnagle +14 more
TL;DR: An approach for evaluating liver histology in DILI is described and numerous associations between pathological findings and clinical presentations are demonstrated that may serve as a foundation for future studies correlating D ILI pathology with its causality and outcome.
Journal ArticleDOI
Volunteer Blood Donors with Antibody to Hepatitis C Virus: Clinical, Biochemical, Virologic, and Histologic Features
A. Obaid Shakil,Cathy Conry-Cantilena,Harvey J. Alter,Paul H. Hayashi,David E. Kleiner,Valeria Tedeschi,Krzysztof Krawczynski,Hari S. Conjeevaram,Richard Sallie,Adrian M. Di Bisceglie +9 more
TL;DR: The clinical significance of the presence of anti-HCV in volunteer, apparently healthy blood donors remains uncertain because most of these donors have chronic hepatitis, despite the absence of symptoms or abnormal serum aminotransferase levels.
Journal ArticleDOI
Liver Transplantation for Hepatocellular Carcinoma
TL;DR: The usefulness of chemotherapy and local ablative treatment for HCC prior to transplantation remains unclear, and cadaveric graft shortage remains a problem and optimal management during the waiting time must be determined.
Journal ArticleDOI
Declining liver graft quality threatens the future of liver transplantation in the United States
Eric S. Orman,Maria E. Mayorga,Stephanie B. Wheeler,Rachel M. Townsley,Hector Toro-Díaz,Paul H. Hayashi,A. Sidney Barritt +6 more
TL;DR: In this paper, the authors used the United Network for Organ Sharing (UNOS) database to inform a 20-year discrete event simulation estimating liver transplant volume from 2010 to 2030, in part because of worsening donor organ quality.